Adenovirus-mediated FasL gene transfer into human gastric carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

213

HTML

2103

Figures (1-3)

181

Tables (1-2)

169

Sum=2666

Jun 14, 2005 (publication date) through Jul 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jun 14, 2005; 11(22): 3446-3450
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3446

Table 2 Relative in vitro cytotoxicities of various treatments (mean±SD).

^aP<0.05 vs CH-11 or (compared with CH-11 or anti-Fas antibody+ActD),

^bP<0.01 vs ActD (compared with ActD).

Citation: Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol 2005; 11(22): 3446-3450
URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3446.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3446